151 related articles for article (PubMed ID: 19811306)
1. Pathogenesis of Churg-Strauss syndrome: recent insights.
Zwerina J; Axmann R; Jatzwauk M; Sahinbegovic E; Polzer K; Schett G
Autoimmunity; 2009 May; 42(4):376-9. PubMed ID: 19811306
[TBL] [Abstract][Full Text] [Related]
2. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
[TBL] [Abstract][Full Text] [Related]
3. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.
Jakiela B; Sanak M; Szczeklik W; Sokolowska B; Plutecka H; Mastalerz L; Musial J; Szczeklik A
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S23-34. PubMed ID: 21470488
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
5. Update on the pathogenesis of Churg-Strauss syndrome.
Hellmich B; Ehlers S; Csernok E; Gross WL
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S69-77. PubMed ID: 14740430
[TBL] [Abstract][Full Text] [Related]
6. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
7. Churg-Strauss syndrome.
Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
[TBL] [Abstract][Full Text] [Related]
8. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Akiyama K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():73-6. PubMed ID: 18504411
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.
Terrier B; Bièche I; Maisonobe T; Laurendeau I; Rosenzwajg M; Kahn JE; Diemert MC; Musset L; Vidaud M; Sène D; Costedoat-Chalumeau N; Le Thi-Huong D; Amoura Z; Klatzmann D; Cacoub P; Saadoun D
Blood; 2010 Nov; 116(22):4523-31. PubMed ID: 20729468
[TBL] [Abstract][Full Text] [Related]
10. Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17.
Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
Int Arch Allergy Immunol; 2009; 149 Suppl 1():61-5. PubMed ID: 19494507
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations and treatment of Churg-Strauss syndrome.
Baldini C; Talarico R; Della Rossa A; Bombardieri S
Rheum Dis Clin North Am; 2010 Aug; 36(3):527-43. PubMed ID: 20688248
[TBL] [Abstract][Full Text] [Related]
12. [Update Churg-Strauss syndrome].
Moosig F; Hellmich B
Z Rheumatol; 2012 Nov; 71(9):765-70. PubMed ID: 23138554
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
14. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.
Dallos T; Heiland GR; Strehl J; Karonitsch T; Gross WL; Moosig F; Holl-Ulrich C; Distler JH; Manger B; Schett G; Zwerina J
Arthritis Rheum; 2010 Nov; 62(11):3496-503. PubMed ID: 20669282
[TBL] [Abstract][Full Text] [Related]
15. Churg-Strauss Syndrome: an evolving paradigm.
Ramentol-Sintas M; Martínez-Valle F; Solans-Laqué R
Autoimmun Rev; 2012 Dec; 12(2):235-40. PubMed ID: 22796280
[TBL] [Abstract][Full Text] [Related]
16. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
17. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Churg-Strauss syndrome: eotaxin-3 makes it easier.
Buzio C; Oliva E
Rheumatology (Oxford); 2011 Oct; 50(10):1737-8. PubMed ID: 21292740
[No Abstract] [Full Text] [Related]
19. Churg-Strauss syndrome: update on clinical, laboratory and therapeutic aspects.
Keogh KA; Specks U
Sarcoidosis Vasc Diffuse Lung Dis; 2006 Mar; 23(1):3-12. PubMed ID: 16933465
[TBL] [Abstract][Full Text] [Related]
20. Churg-Strauss syndrome: update on pathophysiology and treatment.
Vaglio A; Moosig F; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):24-30. PubMed ID: 22089097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
